Adverse effects of low occupational cadmium exposure on renal and oxidative stress biomarkers in solderers

Occupational and Environmental Medicine

Volumn 70, Issue 2, 2013, Pages 108-113

  Hambach, Ramona ^a,b   Lison, Dominique ^c   D'Haese, Patrick ^a   Weyler, Joost ^a   François, Guido ^a   De Schryver, Antoon ^a   Manuel Y Keenoy, Begoña ^a   Van Soom, Ulrik ^b   Caeyers, Tine ^b   Van Sprundel, Marc ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Occupational Health Service   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; ADVANCED OXIDATION PROTEIN PRODUCT; ALKALINE PHOSPHATASE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CADMIUM; GLUTATHIONE PEROXIDASE; N ACETYL BETA GLUCOSAMINIDASE; REACTIVE OXYGEN METABOLITE; RETINOL BINDING PROTEIN; SUPEROXIDE DISMUTASE;

ADULT; AGE; ARTICLE; BLOOD LEVEL; HUMAN; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OCCUPATION; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING HABIT; SOLDERER; URINE LEVEL;

EID: 84872775887     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2012-100887     Document Type: Article

References (40)

1. Järup L. Cadmium overload and toxicity. Nephrol Dial Transplant 2002;17: 35-9.
2. Kido T, Kobayashi E, Hayano M, et al. Significance of elevated urinary human intestinal alkaline phosphatase in Japanese people exposed to environmental cadmium. Toxicol Lett 1995;80:49-54.
3. Chaumont A, De Winter F, Dumont X, et al. The threshold level of urinary cadmium associated with increased urinary excretion of retinol-binding protein and beta 2-microglobulin: a re-assessment in a large cohort of nickel-cadmium battery workers. Occup Environ Med 2011;68:257-64.
4. Fowler B. Monitoring of human populations for early markers of cadmium toxicity: a review. Toxicol Appl Pharmacol 2009;238:294-300.
5. Weaver VM, Kim NS, Jaar BG, et al. Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med 2011;68:250-6.
6. Devi SS, Biswas AR, Biswas RA, et al. Heavy metal status and oxidative stress in diesel engine tuning workers of central Indian Population. J Occup Environ Med 2007;49:1228-34.
7. Garçon G, Leleu B, Marez T, et al. Biomonitoring of the adverse effects induced by the chronic exposure to lead and cadmium on kidney function: usefulness of alpha-glutathione S-transferase. Sci Total Environ 2007;377:165-72.
8. Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals 2010;23:783-92.
9. Wieloch M, Kamiński P, Ossowska A, et al. Do toxic heavy metals affect antioxidant defense mechanisms in humans? Ecotoxicol Environ Saf 2012;78:195-205.
10. Smith NJ, Topping MD, Stewart JD, et al. Occupational cadmium exposure in jig solderers. Br J Ind Med 1986;43:663-6.
11. Mason HJ, Williams N, Armitage S, et al. Follow up of workers previously exposed to silver solder containing cadmium. Occup Environ Med 1999;56:553-8.
12. Joseph P. Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 2009;238:272-9.
13. Lauwerys R, Hoet P. Industrial chemical exposure: guidelines for biological monitoring. Boca Raton, FL: Lewis Publishers, 1993.
14. WHO 1996. Biological monitoring of chemical exposure in the workplace. Vol 1. Geneva: World Health Organization.
15. Barr DB, Wilder LC, Caudill SP, et al. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192-200.
16. D'Haese PC, Lamberts LV, Liang L, et al. Elimination of matrix and spectral interferences in the measurement of lead and cadmium in urine and blood by electrothermal atomic absorption spectrometry with deuterium background correction. Clin Chem 1991;37:1583-8.
17. Verpooten GF, Nuyts GD, Hoylaerts MF, et al. Immunoassay in urine of a specific marker for proximal tubular S3 segment. Clin Chem 1992;38:642-7.
18. Bernard AM, Lauwerys RR. Continuous-flow system for automation of latex immunoassay by particle counting. Clin Chem 1983;29:1007-11.
19. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-13.
20. Aller MA, Garcia-Fernandez MI, Sanchez-Patan F, et al. Plasma redox status is impaired in the portacaval shunted rat - the risk of the reduced antioxidant ability. Comp Hepatol 2008;7:1.
21. Järup L, Persson B, Elinder CG. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup Environ Med 1995;52:818-22.
22. Järup L, Hellström L, Alfvén T, et al. Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 2000;57:668-72.
23. Garçon G, Leleu B, Zerimech F, et al. Biologic markers of oxidative stress and nephrotoxicity as studied in biomonitoring of adverse effects of occupational exposure to lead and cadmium. J Occup Environ Med 2004;46:1180-6.
24. Åkesson A, Lundh T, Vahter M, et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005;113:1627-31.
25. Navas-Acien A, Tellez-Plaza M, Guallar E, et al. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 2009;170:1156-64.
26. Bernard A, Thielemans N, Roels H, et al. Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 1995;52:177-80.
27. Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology 2008;245:182-93.
28. Noonan CW, Sarasua SM, Campagna D, et al. Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ Health Perspect 2002;110:151-5.
29. Moriguchi J, Inoue Y, Kamiyama S, et al. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted area. Toxicol Lett 2009;190:1-8.
30. Taylor SA, Chivers ID, Price RG, et al. The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ Res 1997;75:23-33.
31. Thomas LD, Hodgson S, Nieuwenhuijsen M, et al. Early kidney damage in a population exposed to cadmium and other heavy metals. Environ Health Perspect 2009;117:181-4.
32. Lauwerys RR, Bernard AM, Roels HA, et al. Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem 1994;40:1391-4.
33. D'Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003;12:639-43.
34. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001;1:529-39.
35. Valko M, Rhodes C, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40.
36. Thévenod F. Cadmium and cellular signaling cascades: to be or not to be? Toxicol Appl Pharmacol 2009;238:221-39.
37. Matés JM, Segura JA, Alonso FJ, et al. Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. Free Radic Biol Med 2010;49:1328-41.
38. Han SG, Kim Y, Kashon ML, et al. Correlates of oxidative stress and free-radical activity in serum from asymptomatic shipyard welders. Am J Respir Crit Care Med 2005;172:1541-8.
39. Liu HH, Lin MH, Liu PC, et al. Health risk assessment by measuring plasma malondialdehyde (MDA), urinary 8-hydroxydeoxyguanosine (8-OH-dG) and DNA strand breakage following metal exposure in foundry workers. J Hazard Mater 2009;170:699-704.
40. Engström KS, Vahter M, Johansson G, et al. Chronic exposure to cadmium and arsenic strongly influences concentrations of 8-oxo-7,8-dihydro-2'- deoxyguanosine in urine. Free Radic Biol Med 2010;48:1211-17.